Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,290,709
+$4,637,590 QoQ
Shares Held
16,633,368
+48.8% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Dec 31, 2022CallValue
$205,700
CallShares
85,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. GERN ranks #109 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in GERN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,290,709 | 16,633,368 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,653,119 | 11,176,591 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,350,204 | 16,174,398 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $29,191,129 | 21,307,395 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,840,079 | 9,815,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,936,556 | 8,136,200 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $48,179,932 | 13,610,151 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $81,452,015 | 17,940,973 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,902,157 | 11,297,679 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,489,249 | 4,390,682 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,710,649 | 3,180,403 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $7,461,258 | 3,519,462 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,968,181 | 3,416,879 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,201,605 | 2,397,053 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,771,746 | 1,145,350 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $205,700 | 85,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $198,900 | 85,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $2,170,854 | 927,716 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,162,365 | 749,913 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $694,187 | 510,433 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $505,988 | 414,746 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $665,630 | 485,862 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $404,135 | 286,621 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $370,054 | 234,212 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $488,219 | 307,057 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $452,340 | 259,966 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $773,533 | 354,832 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $329,468 | 276,865 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||